This is a translation of the original article in Portuguese. Read the original (Português).
Weight-loss drugs are now present in more households in the United Kingdom than vegetarians are. According to data from the consultancy Worldpanel, published on the front page of the British newspaper The Times, 8.5% of the country’s households have at least one person who uses medications such as Mounjaro and Wegovy. Households with vegetarians account for 5.5%.
GLP-1 drugs, the group to which these two products belong, are also already affecting the food industry’s bottom line. According to the survey, they have reduced grocery spending by about 1 billion pounds a year.
Another finding highlighted by The Times concerns who is using them. The number of men taking these medications has almost doubled since February, which suggests that use is spreading beyond the group that, until now, has driven demand.
What the numbers show is that weight-loss medication is no longer a niche. Having become part of the routine of one in every twelve British families, it is now changing what goes into the shopping cart and, as a result, what retailers sell.
For Brazilian readers, the British case works as an indicator of what could happen in Brazil, on a different scale, in the food market and in household budgets. Any comparison with Brazil depends on factors such as the price of the drugs and access to them, including through the Unified Health System (SUS), Brazil’s public health system, which are points to watch.
The comparison with vegetarians helps put the change in perspective. A diet that already shapes menus, packaging and retail promotions, vegetarianism now trails GLP-1 users in how many British households it reaches.
Reporting from The Times (Capa, p. 1 (Reino Unido)).
Deixe um comentário